Black Diamond Therapeutics Inc (BDTX) Insider Transactions
2.71 ↑0.02 (0.74%)
As of December 31, 1969, 7:00pm EST.
Insider Transactions
| Transaction Date | Owner | Role | Action | Price | Total | Shares Remaining | Price Since | Source |
|---|---|---|---|---|---|---|---|---|
| 2021-05-12 | Brent Hatzis-Schoch | Insider | Sold 4 Shares | $27.42 | $110 | 12 | -90.12% | Link |
| 2021-05-03 | Christopher D Roberts | Insider | Sold 2 Shares | $26.64 | $53 | 5 | -89.83% | Link |
| 2021-04-12 | Brent Hatzis-Schoch | Insider | Sold 4 Shares | $25 | $100 | 12 | -89.16% | Link |
| 2021-04-05 | Christopher D Roberts | Insider | Sold 2 Shares | $25.54 | $51 | 5 | -89.39% | Link |
| 2021-03-03 | Christopher D Roberts | Insider | Sold 2 Shares | $26.1 | $52 | 0 | -89.62% | Link |
| 2021-02-12 | Brent Hatzis-Schoch | Insider | Sold 4 Shares | $27.23 | $109 | 12 | -90.05% | Link |
| 2021-02-03 | Christopher D Roberts | Insider | Sold 2 Shares | $25.35 | $51 | 5 | -89.31% | Link |
| 2021-01-12 | Brent Hatzis-Schoch | Insider | Sold 11 Shares | $34.03 | $374 | 12 | -92.04% | Link |
| 2021-01-08 | Thomas Leggett | CFO | Sold 3 Shares | $33.94 | $102 | 3 | -92.02% | Link |
| 2021-01-04 | Christopher D Roberts | Insider | Sold 2 Shares | $31.41 | $63 | 5 | -91.37% | Link |
| 2020-12-14 | Brent Hatzis-Schoch | Insider | Sold 4 Shares | $34.95 | $140 | 7 | -92.25% | Link |
| 2020-12-08 | Thomas Leggett | CFO | Sold 3 Shares | $33.78 | $101 | 3 | -91.98% | Link |
| 2020-12-03 | Christopher D Roberts | Insider | Sold 2 Shares | $32.42 | $65 | 2 | -91.64% | Link |
| 2020-12-01 | David M Epstein | Insider | Sold 12 Shares | $32.71 | $393 | 714 | -91.72% | Link |
| 2020-11-30 | Bradley J Phd Bolzon | Director | Sold 10 Shares | $33.15 | $332 | 21 | -91.83% | Link |
| 2020-11-18 | Bradley J Phd Bolzon | Director | Sold 536 Shares | $33.09 | $17,736 | 15 | -91.81% | Link |
| 2020-11-18 | Versant Venture Capital Vi, L. | Major Shareholder | Sold 473 Shares | $33.09 | $15,652 | 0 | -91.81% | Link |
| 2020-11-16 | Bradley J Phd Bolzon | Director | Sold 200 Shares | $33.01 | $6,602 | 15 | -91.79% | Link |
| 2020-11-16 | Versant Venture Capital Vi, L. | Major Shareholder | Sold 177 Shares | $33.01 | $5,843 | 0 | -91.79% | Link |
| 2020-11-12 | Bradley J Phd Bolzon | Director | Sold 15 Shares | $34.15 | $512 | 14 | -92.06% | Link |
| 2020-11-12 | Versant Venture Capital Vi, L. | Major Shareholder | Sold 13 Shares | $34.15 | $444 | 0 | -92.06% | Link |
| 2020-11-09 | Bradley J Phd Bolzon | Director | Sold 6 Shares | $33.06 | $198 | 10 | -91.80% | Link |
| 2020-11-09 | Versant Venture Capital Vi, L. | Major Shareholder | Sold 5 Shares | $33.06 | $165 | 0 | -91.80% | Link |
| 2020-11-09 | Thomas Leggett | CFO | Sold 3 Shares | $32.96 | $99 | 3 | -91.78% | Link |
| 2020-11-06 | Bradley J Phd Bolzon | Director | Sold 3 Shares | $33.13 | $99 | 10 | -91.82% | Link |
| 2020-11-06 | Versant Venture Capital Vi, L. | Major Shareholder | Sold 2 Shares | $33.13 | $66 | 0 | -91.82% | Link |
| 2020-11-04 | Bradley J Phd Bolzon | Director | Sold 2 Shares | $33.14 | $66 | 10 | -91.82% | Link |
| 2020-11-04 | Versant Venture Capital Vi, L. | Major Shareholder | Sold 2 Shares | $33.14 | $66 | 0 | -91.82% | Link |
| 2020-11-02 | David M Epstein | Insider | Sold 12 Shares | $31.14 | $374 | 723 | -91.30% | Link |
| 2020-10-26 | Bradley J Phd Bolzon | Director | Sold 8 Shares | $33.3 | $266 | 10 | -91.86% | Link |
| 2020-10-26 | Versant Venture Capital Vi, L. | Major Shareholder | Sold 7 Shares | $33.3 | $233 | 0 | -91.86% | Link |
| 2020-10-19 | Bradley J Phd Bolzon | Director | Sold 4 Shares | $33.43 | $134 | 10 | -91.89% | Link |
| 2020-10-19 | Versant Venture Capital Vi, L. | Major Shareholder | Sold 3 Shares | $33.43 | $100 | 0 | -91.89% | Link |
| 2020-10-16 | Bradley J Phd Bolzon | Director | Sold 8 Shares | $33.57 | $269 | 10 | -91.93% | Link |
| 2020-10-16 | Versant Venture Capital Vi, L. | Major Shareholder | Sold 7 Shares | $33.57 | $235 | 0 | -91.93% | Link |
| 2020-10-14 | Bradley J Phd Bolzon | Director | Sold 5 Shares | $33.09 | $165 | 10 | -91.81% | Link |
| 2020-10-14 | Versant Venture Capital Vi, L. | Major Shareholder | Sold 4 Shares | $33.09 | $132 | 0 | -91.81% | Link |
| 2020-10-12 | Brent Hatzis-Schoch | Insider | Sold 4 Shares | $32.7 | $131 | 7 | -91.71% | Link |
| 2020-10-12 | Versant Venture Capital Vi, L. | Major Shareholder | Sold 353 Shares | $33.11 | $11,688 | 0 | -91.82% | Link |
| 2020-10-12 | Bradley J Phd Bolzon | Director | Sold 400 Shares | $33.11 | $13,244 | 10 | -91.82% | Link |
| 2020-10-08 | Thomas Leggett | CFO | Sold 3 Shares | $33.53 | $101 | 3 | -91.92% | Link |
| 2020-10-08 | Bradley J Phd Bolzon | Director | Sold 18 Shares | $33.47 | $602 | 10 | -91.90% | Link |
| 2020-10-08 | Versant Venture Capital Vi, L. | Major Shareholder | Sold 16 Shares | $33.47 | $536 | 0 | -91.90% | Link |
| 2020-10-06 | Bradley J Phd Bolzon | Director | Sold 18 Shares | $33.26 | $599 | 8 | -91.85% | Link |
| 2020-10-06 | Versant Venture Capital Vi, L. | Major Shareholder | Sold 15 Shares | $33.26 | $499 | 0 | -91.85% | Link |
| 2020-10-05 | Christopher D Roberts | Insider | Sold 2 Shares | $31.28 | $63 | 2 | -91.34% | Link |
| 2020-10-01 | David M Epstein | Insider | Sold 12 Shares | $30.33 | $364 | 732 | -91.06% | Link |
| 2020-09-30 | Robert Alexander Ingram | Director | Bought 5 Shares | $30.46 | $152 | 5 | -91.10% | Link |
| 2020-09-14 | Brent Hatzis-Schoch | Insider | Sold 4 Shares | $31.04 | $124 | 7 | -91.27% | Link |
| 2020-09-14 | Thomas Leggett | CFO | Sold 3 Shares | $31 | $93 | 3 | -91.26% | Link |
$BDTX has just been halted from trading due to volatility.
$BDTX who else finds themselves here after liquidating their positions for a loss only to bash on how seriously fcked up the stock market is
$BDTX who loaded up??
$BDTX Shorts talk the talk but cant walk the walk
$BDTX bought more
$BDTX hang tight
ignore fud and buy dips if you can
everyone be okay????
$BDTX Like if you’re a bull
$BDTX BUY BUY BUY
$BDTX Fake dip news.
$BDTX come to papa